He hopena pale ikaika kēia huahana i ka hapa nui o nā maʻi bacteria gram-positive a maikaʻi ʻole. ʻAʻole hiki ke hoʻohana i ka waika folic i loko o ke kaiapuni a puni, hiki ke hoʻohana wale i ka p-aminobenzoic acid a me ka dihydropteridine, ma lalo o ka hana o ka bacteria dihydrofolate synthase e synthesize tetrahydrofolate, tetrahydrofolate hoʻāla i ka synthesis o purine, thymine nucleoside he mea nui i ka hoʻoili ʻana o kahi hui kalapona. ʻO nā lāʻau lapaʻau Sulfa e like me ka p-aminobenzoic acid, a hiki ke hoʻokūkū me ka p-aminobenzoic acid no ka dihydrofolate synthetase i loko o ka maʻi bacteria, keʻakeʻa i ka synthesis o dihydrofolate, ka hopena hopena i ka synthesis o ka waikawa nucleic, a ke kāohi i ka ulu a me ka hana hou ʻana o ka bacteria. Hiki ke hoʻohālikelike ʻia ka hana o nā lāʻau sulfanilamide e nā lāʻau lapaʻau e hiki ke hoʻololi i ka amino benzoic acid, e like me procaine a me tetracaine. Eia kekahi, hiki i nā huahana hoʻoheheʻe a me ka ʻiʻo ke hāʻawi i nā mea pono no ka ulu ʻana o ka maʻi bacteria, a loaʻa nā hopena antagonistic i nā sulfonamides. ʻO Trimethoprim kahi synergist antibacterial e pale i ka hana o ka dihydrofolate reductase. Hiki i ka hui ʻana o nā mea ʻelua ke hana i kahi hopena synergistic e hoʻomaikaʻi i ka hopena antibacterial.
ʻO nā lāʻau antibacterial Sulfonamides, ka hapa nui o nā hua bacteria gram-positive a me nā bacteria maikaʻi ʻole i ka hopena inhibition ikaika, hoʻohana ʻia i nā holoholona a me nā moa escherichia coli a me ka maʻi pasteurella. Hiki ke hoʻohana ʻia no ka toxoplasmosis puaʻa, ka moa a me ka coccidiosis rabbit.
Ma keia huahana. No ka hoʻoponopono i loko: ʻO kēlā me kēia lā, no ka 1kg kaumaha o ke kino, 32mg no ka puaʻa a me ka moa; no nā puaʻa, no 5 a 10 mau lā; a me ka moa, no 3 a 6 lā. ʻO ka hānai ʻana: ʻO kēia huahana 100g hui 500 ~ 750kg, hoʻohana mau i ka puaʻa 5 ~ 10 mau lā, hoʻohana mau i ka moa 3 ~ 6 lā. Mea inu: 100g o kēia huahana i hui ʻia me ka wai 1000- 1500kg, hoʻohana ʻia no 5 ~ 10 mau lā no nā puaʻa, 3 ~ 6 mau lā no nā moa.
